The Journal of Immunology, Vol 144, Issue 6 2152-2158, Copyright © 1990 by American Association of Immunologists

ARTICLES

HIV-1 transmission and function of virus-infected monocytes/macrophages

DL Mann, S Gartner, F Le Sane, H Buchow and M Popovic
Laboratory of Viral Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, MD 20895.

Monocyte/macrophages (MM) were isolated from HIV-1 seronegative individuals, infected with HIV-1 and examined for their ability to infect autologous T lymphocytes with and without concomitant presentation of exogenous Ag. HIV-1-infected MM presented tetanus toxin (TT) and streptokinase to T cells (as measured by [3H]thymidine incorporation) comparable to presentation by uninfected MM. In these studies, it was observed that HIV-1-infected MM without additional exogenous Ag stimulated autologous T lymphocytes, however, to a lesser degree than with TT and streptokinase. Virus production in T cells appeared to be relative to the degree of stimulation with the highest levels of stimulation and infection observed when T cells were exposed to HIV-1-infected TT-presenting MM. Studies were carried out to examine some of the restricting elements in MM-mediated infection of T lymphocytes with and without TT presentation. Antibodies to CD4, as well as soluble immunopurified gp120, blocked cell-mediated infection indicating that infection of T cells was through the CD4 molecule as has been demonstrated with cell-free virus. In addition, soluble gp120 inhibited Ag presentation by HIV-1-infected and uninfected MM. mAb to MHC class II Ag HLA-DR and -DP blocked T cell infection by HIV-1- infected MM with and without presentation of TT. No effect was observed with mAb to MHC class I Ag. These results indicate that virus transmission to T lymphocytes can be mediated by HIV-1-infected MM and that these cells maintain their function as APC. Activation of T cells appears to be important in the process of T cell infection in this system inasmuch as antibodies that block Ag presentation and thus a T cell proliferative signal inhibit infection.

This article has been cited by other articles:

				A. Brown, S. Gartner, T. Kawano, N. Benoit, and C. Cheng-Mayer HLA-A2 down-regulation on primary human macrophages infected with an M-tropic EGFP-tagged HIV-1 reporter virus J. Leukoc. Biol., September 1, 2005; 78(3): 675 - 685. [Abstract] [Full Text] [PDF]

				Y. Emori, T. Ikeda, T. Ohashi, T. Masuda, T. Kurimoto, M. Takei, and M. Kannagi Inhibition of human immunodeficiency virus type 1 replication by Z-100, an immunomodulator extracted from human-type tubercle bacilli, in macrophages J. Gen. Virol., September 1, 2004; 85(9): 2603 - 2613. [Abstract] [Full Text] [PDF]

				S. D. Lawn, S. T. Butera, and T. M. Folks Contribution of Immune Activation to the Pathogenesis and Transmission of Human Immunodeficiency Virus Type 1 Infection Clin. Microbiol. Rev., October 1, 2001; 14(4): 753 - 777. [Abstract] [Full Text] [PDF]

				X. Wang and D. E. Lewis CD86 expression correlates with amounts of HIV produced by macrophages in vitro J. Leukoc. Biol., March 1, 2001; 69(3): 405 - 413. [Abstract] [Full Text]

				G. Zybarth, N. Reiling, H. Schmidtmayerova, B. Sherry, and M. Bukrinsky Activation-Induced Resistance of Human Macrophages to HIV-1 Infection In Vitro J. Immunol., January 1, 1999; 162(1): 400 - 406. [Abstract] [Full Text] [PDF]

				H. Chen, I. George, and K. Sperber Effect of Ethanol on Monocytic Function in Human Immunodeficiency Virus Type 1 Infection Clin. Vaccine Immunol., November 1, 1998; 5(6): 790 - 798. [Abstract] [Full Text]

				R. Bernier, B. Barbeau, M. J. Tremblay, and M. Olivier The Lipophosphoglycan of Leishmania donovani Up-Regulates HIV-1 Transcription in T Cells Through the Nuclear Factor-{kappa}B Elements J. Immunol., March 15, 1998; 160(6): 2881 - 2888. [Abstract] [Full Text] [PDF]

				C. A. Thomas, O. K. Weinberger, B. L. Ziegler, S. Greenberg, I. Schieren, S. C. Silverstein, and J. El Khoury Human Immunodeficiency Virus-1 env Impairs Fcgamma Receptor-Mediated Phagocytosis Via a Cyclic Adenosine Monophosphate-Dependent Mechanism Blood, November 1, 1997; 90(9): 3760 - 3765. [Abstract] [Full Text] [PDF]